Adjusted for covariates , fenofibrate reduced total cardiovascular outcomes ( cardiovascular death , fatal and non-fatal stroke and carotid and coronary revascularisation ) by @ % in women ( @ % CI @ % , @ % ; p = @ ) and @ % in men ( @ % CI -@ % , @ % ; p = @ ) with no treatment-by-sex interaction ( p > @ ) .